References
- Global Burden of Disease Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–1788. DOI: 10.1016/S0140-6736(18)32203-7
- Lund LH, Crespo-Leiro MG, Laroche C, Zaliaduonyte D, Saad AM, Fonseca C, et al. Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III Registry. Eur J Heart Fail. 2024;26(12):2487–2501. DOI: 10.1002/ejhf.3445
- McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726. DOI: 10.1093/eurheartj/ehab368
- Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895–e1032. DOI: 10.1161/CIR.0000000000001073
- Khan MS, Shahid I, Bennis A, Rakisheva A, Metra M, Butler J. Global epidemiology of heart failure. Nat Rev Cardiol. 2024;21(10):717–734. DOI: 10.1038/s41569-024-01046-6
- Becher PM, Lund LH, Coats AJS, Savarese G. An update on global epidemiology in heart failure. Eur Heart J. 2022;43(32):3005–3007. DOI: 10.1093/eurheartj/ehac248
- Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: A comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118(17):3272–3287. DOI: 10.1093/cvr/cvac013
- Dokainish H, Teo K, Zhu J, Roy A, AlHabib KF, ElSayed A, et al. Global mortality variations in patients with heart failure: Results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study. Lancet Glob Health. 2017;5(7):e665–e672.
- Walli-Attaei M, Joseph P, Johansson I, Sliwa K, Lonn E, Maggioni AP, et al. Characteristics, management, and outcomes in women and men with congestive heart failure in 40 countries at different economic levels: An analysis from the Global Congestive Heart Failure (G-CHF) registry. Lancet Glob Health. 2024;12(3):e396–e405. DOI: 10.1016/S2214-109X(23)00557-0
- Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail. 2020;22(8):1342–1356. DOI: 10.1002/ejhf.1858
- Coates MM, Ezzati M, Robles Aguilar G, Kwan GF, Vigo D, Mocumbi AO, et al. Burden of disease among the world’s poorest billion people: An expert-informed secondary analysis of Global Burden of Disease estimates. PLoS One. 2021;16(8):
e0253073 . DOI: 10.1371/journal.pone.0253073 - Bukhman G, Mocumbi AO, Horton R. Reframing NCDs and injuries for the poorest billion: A Lancet Commission. Lancet. 2015;386(10000):1221–1222. DOI: 10.1016/S0140-6736(15)00278-0
- Jarvis JD, Townsend B. Universal health coverage for the poorest billion: Justice and equity considerations. Lancet. 2021;397(10273):473–474. DOI: 10.1016/S0140-6736(20)32382-5
- Pabon MA, Vaduganathan M, Lam CSP. Is the optimal dose of heart failure medical therapy different in women and men? Eur J Heart Fail. 2024;26(8):1699–1702. DOI: 10.1002/ejhf.3320
- Ravera A, Santema BT, de Boer RA, Anker SD, Samani NJ, Lang CC, et al. Distinct pathophysiological pathways in women and men with heart failure. Eur J Heart Fail. 2022;24(9):1532–1544. DOI: 10.1002/ejhf.2534
- Keates AK, Mocumbi AO, Ntsekhe M, Sliwa K, Stewart S. Cardiovascular disease in Africa: Epidemiological profile and challenges. Nat Review Cardiol. 2017;14(5):273–293. DOI: 10.1038/nrcardio.2017.19
- Stewart S, Wilkinson D, Hansen C, Vaghela V, Mvungi R, McMurray J, et al. Predominance of heart failure in the Heart of Soweto Study cohort: Emerging challenges for urban African communities. Circulation. 2008;118(23):2360–2367. DOI: 10.1161/CIRCULATIONAHA.108.786244
- Ogah OS, Sliwa K, Akinyemi JO, Falase AO, Stewart S. Hypertensive heart failure in Nigerian Africans: Insights from the Abeokuta Heart Failure Registry. J Clin Hypertens (Greenwich). 2015;17(4):263–272. DOI: 10.1111/jch.12496
- Mocumbi AO, Stewart S, Patel S, Al-Delaimy WK. Cardiovascular effects of indoor air pollution from solid fuel: Relevance to sub-Saharan Africa. Curr Environ Health Rep. 2019;6(3):116–126. DOI: 10.1007/s40572-019-00234-8
- Stewart S, Carrington M, Pretorius S, Methusi P, Sliwa K. Standing at the crossroads between new and historically prevalent heart disease: effects of migration and socio-economic factors in the Heart of Soweto cohort study. Eur Heart J. 2011;32(4):492–499. DOI: 10.1093/eurheartj/ehq439
- Sliwa K, Viljoen CA, Stewart S, Miller MR, Prabhakaran D, Kumar RK, et al. Cardiovascular disease in low- and middle-income countries associated with environmental factors. Eur J Prev Cardiol. 2024;31(6):688–697. DOI: 10.1093/eurjpc/zwad388
- Sliwa K. Heart failure can affect everyone: The ESC Geoffrey Rose lecture. Eur Heart J. 2020;41(12):1298–1306. DOI: 10.1093/eurheartj/ehaa084
- Agbor VN, Essouma M, Ntusi NAB, Nyaga UF, Bigna JJ, Noubiap JJ. Heart failure in sub-Saharan Africa: A contemporaneous systematic review and meta-analysis. Int J Cardiol. 2018;257:207–215. DOI: 10.1016/j.ijcard.2017.12.048
- Mwita JC, Joubert A, Saidu H, Sani MU, Damasceno A, Mocumbi AO, et al. Objectively measured medication adherence using assays for carvedilol and enalaprilat in patients with heart failure in Mozambique and Nigeria. Int J Cardiol Cardiovasc Risk Prev. 2023;19:200213. DOI: 10.1016/j.ijcrp.2023.200213
- Siddikatou D, Mandeng Ma Linwa E, Ndobo V, Nkoke C, Mouliom S, Ndom MS, et al. Heart failure outcomes in sub-Saharan Africa: A scoping review of recent studies conducted after the 2022 AHA/ACC/HFSA guideline release. BMC Cardiovasc Disord. 2025;25(1):302. DOI: 10.1186/s12872-025-04756-y
- Bazargani YT, Ugurlu M, de Boer A, Leufkens HGM, Mantel-Teeuwisse AK. Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries. BMC Cardiovasc Disord. 2018;18(1):126. DOI: 10.1186/s12872-018-0858-5
- Agbor VN, Ntusi NAB, Noubiap JJ. An overview of heart failure in low- and middle-income countries. Cardiovasc Diagn Ther. 2020;10(2):244–251. DOI: 10.21037/cdt.2019.08.03
- Mbanze I, Spracklen TF, Jessen N, Damasceno A, Sliwa K. Heart failure in low-income and middle-income countries. Heart (British Cardiac Society). 2025;111(8):341–351. DOI: 10.1136/heartjnl-2024-324176
- Dzudie A, Njume E, Abanda M, Aminde L, Hamadou B, Dzekem B, et al. Availability, cost and affordability of essential cardiovascular disease medicines in the south west region of Cameroon: Preliminary findings from the Cameroon science for disease study. PloS One. 2020;15(3):
e0229307 . DOI: 10.1371/journal.pone.0229307 - Averbuch T, Esfahani M, Khatib R, Kayima J, Miranda JJ, Wadhera RK, et al. Pharmaco-disparities in heart failure: A survey of the affordability of guideline recommended therapy in 10 countries. ESC Heart Fail. 2023;10(5):3152–3163. DOI: 10.1002/ehf2.14468
- Sani MU, Davison BA, Cotter G, Damasceno A, Mayosi BM, Ogah OS, et al. Echocardiographic predictors of outcome in acute heart failure patients in sub-Saharan Africa: Insights from THESUS-HF. Cardiovasc J Afr. 2017;28(1):60–67. DOI: 10.5830/CVJA-2016-070
- Sani MU, Cotter G, Davison BA, Mayosi BM, Damasceno A, Edwards C, et al. Symptoms and signs of heart failure at admission and discharge and outcomes in the sub-Saharan Acute Heart Failure (THESUS-HF) registry. J Card Fail. 2017;23(10):739–742. DOI: 10.1016/j.cardfail.2016.09.016
- Ogah OS, Davison BA, Sliwa K, Mayosi BM, Damasceno A, Sani MU, et al. Gender differences in clinical characteristics and outcome of acute heart failure in sub-Saharan Africa: Results of the THESUS-HF study. Clin Res Cardiol. 2015;104(6):481–490. DOI: 10.1007/s00392-015-0810-y
- Dzudie A, Milo O, Edwards C, Cotter G, Davison BA, Damasceno A, et al. Prognostic significance of ECG abnormalities for mortality risk in acute heart failure: Insight from the sub-Saharan Africa Survey of Heart Failure (THESUS-HF). J Card Fail. 2014;20(1):45–52. DOI: 10.1016/j.cardfail.2013.11.005
- Sliwa K, Davison BA, Mayosi BM, Damasceno A, Sani M, Ogah OS, et al. Readmission and death after an acute heart failure event: Predictors and outcomes in sub-Saharan Africa: Results from the THESUS-HF registry. Eur Heart J. 2013;34(40):3151–3159. DOI: 10.1093/eurheartj/eht393
- Damasceno A, Mayosi BM, Sani M, Ogah OS, Mondo C, Ojji D, et al. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Arch Intern Med. 2012;172(18):1386–1394. DOI: 10.1001/archinternmed.2012.3310
- Mebazaa A, Davison B, Chioncel O, Cohen-Solal A, Diaz R, Filippatos G, et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): A multinational, open-label, randomised, trial. Lancet. 2022;400(10367):1938–1952. DOI: 10.1016/S0140-6736(22)02076-1
- Cotter G, Deniau B, Davison B, Edwards C, Adamo M, Arrigo M, et al. Optimization of evidence-based heart failure medications after an acute heart failure admission: A secondary analysis of the STRONG-HF randomized clinical trial. JAMA Cardiol. 2024;9(2):114–124. DOI: 10.1001/jamacardio.2023.4553
- Tomasoni D, Davison B, Adamo M, Pagnesi M, Mebazaa A, Edwards C, et al. Safety indicators in patients receiving high-intensity care after hospital admission for acute heart failure: The STRONG-HF trial. J Card Fail. 2024;30(4):525–537.
- The World Bank. World Bank Open Data 2023 [updated 2023]. Washington, DC. Available from:
https://data.worldbank.org/ . - Stewart S, Keates AK, Redfern A, McMurray JJV. Seasonal variations in cardiovascular disease. Nat Rev Cardiol. 2017;14(11):654–664. DOI: 10.1038/nrcardio.2017.76
- Kirschbaum TK, Sudharsanan N, Manne-Goehler J, De Neve JW, Lemp JM, Theilmann M, et al. The association of socioeconomic status with hypertension in 76 low- and middle-income countries. J Am Coll Cardiol. 2022;80(8):804–817. DOI: 10.1016/j.jacc.2022.05.044
- Franco OH, Peeters A, Bonneux L, de Laet C. Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: Life course analysis. Hypertension. 2005;46(2):280–286. DOI: 10.1161/01.HYP.0000173433.67426.9b
- Bernabe-Ortiz A, Sanchez JF, Carrillo-Larco RM, Gilman RH, Poterico JA, Quispe R, et al. Rural-to-urban migration and risk of hypertension: Longitudinal results of the PERU MIGRANT study. J Hum Hypertens. 2017;31(1):22–28. DOI: 10.1038/jhh.2015.124
- Bridger T. Childhood obesity and cardiovascular disease. Paediatr Child Health. 2009;14(3):177–182. DOI: 10.1093/pch/14.3.177
- Grillo A, Salvi L, Coruzzi P, Salvi P, Parati G. Sodium intake and hypertension. Nutrients. 2019;11(9). DOI: 10.3390/nu11091970
- Stevens GA, Alkema L, Black RE, Boerma JT, Collins GS, Ezzati M, et al. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. Lancet. 2016;388(10062):e19–e23. DOI: 10.1016/S0140-6736(16)30388-9
- Mocumbi AO, Cebola B, Muloliwa A, Sebastiao F, Sitefane SJ, Manafe N, et al. Differential patterns of disease and injury in Mozambique: New perspectives from a pragmatic, multicenter, surveillance study of 7809 emergency presentations. PLoS One. 2019;14(7):
e0219273 . DOI: 10.1371/journal.pone.0219273 - Sliwa K, Carrington M, Mayosi BM, Zigiriadis E, Mvungi R, Stewart S. Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: Insights from the heart of Soweto study. Eur Heart J. 2010;31(6):719–727. DOI: 10.1093/eurheartj/ehp530
- Beck HE, Zimmermann NE, McVicar TR, Vergopolan N, Berg A, Wood EF. Present and future Koppen-Geiger climate classification maps at 1-km resolution. Sci Data. 2018;5:180214. DOI: 10.1038/sdata.2018.214
